Despite significant strides in prevention and in survivorship, cancer remains a leading cause of death across Europe.

With nearly 200 variations of cancer, the complexity of navigating treatments and optimising resources has risen to the forefront of public debate.

Technological innovations--from AI, to wearables, to advancements in immunotherapy, to CAR-T and radiotherapy treatments, are rapidly redefining patient experiences.

As the digital revolution accelerates, the opportunities for patients to take ownership of their diagnosis, treatments and oncology journey have grown.

How will current data privacy laws such as GDPR impact patient treatments?

How can stakeholders work collaboratively to ensure patient engagement is more than a moral imperative but a tool for driving progress in oncology care?

Will increased patient access to data strengthen relationships with clinicians or create new tensions for care?

What can be learned from regions in Europe like the Nordics, that are taking the lead on meaningful patient collaboration and engagement with emerging technologies?

How can patient engagement strengthen drug discovery, R&D and regulation?